血小板作为潜在的非传统心血管风险因素-在健康捐赠者身上进行的分析.
Patrycja Szymańska1, Bogusława Luzak1, Przemysław Siarkiewicz2
1Department of Haemostasis and Haemostatic Disorders, Chair of Biomedical Sciences, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
International journal of molecular sciences
|October 14, 2023
概括
血小板,除了传统的风险因素,显示链接到心血管疾病 (CVD). 特定的血小板标记与胆固醇,葡萄糖和体重相关,有助于识别高风险个体.
科学领域:
- 心血管研究的心血管研究.
- 血液学 血液学 血液学
- 代谢综合征是代谢综合征.
背景情况:
- 传统的心脏代谢风险因素包括异常的脂质样本,高血糖和高体重.
- 血小板在心血管疾病 (CVD) 发展中的作用正在获得认可.
- 识别新的风险因素对于主动的心血管健康管理至关重要.
研究的目的:
- 在健康个体中确定与心血管风险增加相关的血小板相关参数.
- 探索血小板指数,炎症标志物,反应性和ROS生成与心脏代谢因素之间的关系.
- 评估血小板参数作为非传统心血管疾病风险指标的潜力.
主要方法:
- 评估血小板指数,炎症标志物,反应性和反应性氧物种 (ROS) 的产生.
- 与传统心脏代谢风险因素 (脂质,葡萄糖,体重指数) 的相关性分析.
- 评估特定的比率,如平均血小板体积与淋巴细胞和血小板与HDL胆固醇的比率.
主要成果:
- 总胆固醇和LDL胆固醇与血小板聚合和ROS生成有关.
- 三甘油,葡萄糖和BMI与多重炎症指数 (MII-1,MII-3) 有关.
- 血小板与HDL胆固醇的比率被确定为潜在的预后心脏代谢指标.
结论:
- 血小板参数,特别是分子参数,与心脏代谢风险因素有关.
- 血小板代表非传统的心血管风险因素,是识别高风险个体的关键.
- 需要进一步的研究,以充分阐明血小板在心血管疾病发展和风险分层中的作用.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
538
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
538
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K